Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-02-22 00:00:00 ET · period of report 2023-02-17 · accession 0001209191-23-011655 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-22 | 2023-02-21 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | S - Sale | $293.77 | -4,002 | 40.2K | -9% | -$1.18M |
| 2023-02-22 | 2023-02-17 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | F - Tax | $292.85 | -3,750 | 44.2K | -8% | -$1.10M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-21 | S | D | 1,843 | $294.03 | 41,146 | D | — | — | (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $294.03 (range $293.45 to $294.42). |
| 2 | Common | Common Stock | 2023-02-17 | F | D | 3,750 | $292.85 | 44,248 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-21 | S | D | 36 | $291.01 | 44,212 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-21 | S | D | 1,223 | $292.76 | 42,989 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $292.76 (range $292.25 to $293.12). (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2023-02-21 | S | D | 900 | $294.73 | 40,246 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $294.73 (range $294.47 to $295.37). (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |